AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2022
Mar 12, 2022
33148_dirs_2022-03-11_ed5296c8-dbf8-487b-8387-89821401d2a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2022-03-10
Reporting Person: Malik Fady Ibraham (N/A)
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Capital/Financing Update
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Capital/Financing Update
2026
Mar 2
Earnings Release
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20